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Abstract
Background The accurate determination of the dosage of topical treatments is important given its repercussions on
patient adherence and therapeutic efﬁcacy. Up till now, the ﬁngertip unit calculated by the rule of hands is considered
the gold standard, although its use is associated with several drawbacks.
Objective To compare different methods to estimate the affected body surface area (BSA) and dosage of topical treat-
ments in atopic dermatitis and psoriasis and investigate its reliability, user-friendliness and timing.
Methods In this study, we compared the reliability of three different methods: (i) the ﬁngertip unit calculated by the 1%
hand rule; (ii) a picture-based tool [termed Cutaneous Inﬂammatory Disease Extent Score (CIDES)]; and (iii) a digital draw-
ing tool. Eleven observers scored 40 patients with psoriasis and eczema to assess the inter-rater and intrarater reliability.
Timing was automatically recorded, and user-friendliness was investigated by a questionnaire.
Results An excellent intraclass correlation (ICC) was found for both inter-rater agreement and intrarater agreement for
the picture-based tool (ICC = 0.92 and ICC = 0.96, respectively). The ICCs for drawing the area of involvement on a sil-
houette were 0.89 and 0.93, respectively. Finally, the rule of hands was associated with an increased inter-rater variability
although an excellent intrarater agreement was found (ICC = 0.79 and 0.95, respectively). Automated calculation of the
amount of topical treatment improved reliability, and CIDES was associated with the least variation. CIDES was consid-
ered the preferred method by all observers and was fast to perform (median: 30 s).
Conclusion A picture-based method offered the most advantages (in terms of reliability, speed and user-friendliness)
to estimate the affected BSA and calculate the dosage of topical treatments.
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Introduction
Estimating the dosage of topical treatments and explaining this
information in a reliable way to patients is a long-standing prob-
lem in dermatology. In 1989, the ‘fingertip unit’ (FTU) was
developed as a method to clarify the amount of ointment that
should be used.1 Global charts were developed explaining how
much FTUs are needed to cover entire body parts. However, as
skin diseases are rarely confined to anatomical borders, the FTU
was combined with the rule of hands.2 This method assumes
that for each affected skin area of two palms (=2%), the patient
should use the amount of ointment covering one tip of the index
finger if dispensed in a straight line from a tube with a 5-mm
nozzle (=1 FTU). This quantity approximates a weight of 0.5 g.
The FTU strictly only applies to corticosteroid ointments.
Unfortunately, the method is often used for other substances
(e.g. retinoids, moisturizers, sunscreens) in different topical
vehicle formulations (e.g. creams, gels, foams), where other
dosage regimens may be more appropriate. In daily practice,
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dermatologists use this method only in a small minority of
patients, and despite the fact that many patient websites mention
the FTU, only a minority of patients is familiar with this
method. This illustrates the inherent problems of this technique
in a real-life situation. Physicians often rely on their own profes-
sional experience to estimate the dosage resulting in a high vari-
ability.3
The use of the rule of hands to estimate the affected body sur-
face area (BSA) in skin disorders has been a topic of debate.
First, the assumption that 1 hand corresponds to 1% of the BSA
has been challenged as planimetric measurements showed it rep-
resents approximately 0.78% of the BSA.4 Although this method
has advantages as it requires no additional material/software and
gives a rough estimate, it feels inaccurate in clinical practice due
to the scattered distribution pattern of most inflammatory skin
diseases. Especially in patients with extensive disease, a reliable
estimate is challenging. Despite its long-time use, data on the
inter-rater and intrarater reliability of the rule of hands are lim-
ited for common skin diseases such as psoriasis and eczema.
On the other hand, digital imaging systems are time-consuming
and fail to evaluate the palmoplantar, genital and hair covered
sites.5 In addition, their introduction and widespread availability
are difficult to attain. The need for new standardized (digital)
easy-to-use tools has therefore been emphasized in the literature.3
This study is the first step in the development of a new digital
tool to calculate the dosage of topical treatments. Three different
methods to estimate the extent of psoriasis and atopic dermatitis




Eleven observers with different degrees of medical experience
[three students (6th-year medical school), one physician (non-
dermatologist), three dermatologists with limited years of expe-
rience (<3 years) and four experienced dermatologists scored
pictures of 40 patients (20 psoriasis patients and 20 patients with
atopic dermatitis) using three methods (rule of hands, picture-
based instrument and the drawing tool). Before the first scoring
session, a short introduction during 3–5 min was given to
explain the three scoring tools. The aim (=‘comparison of differ-
ent methods’) was explained to the raters. For each patient, a
fixed time period (range 0.5–12 months) was given, explaining
the duration for which the topical treatment had to be pre-
scribed. The raters were asked how much ointment they would
advise during this period and how much (=percentage of pre-
scribed amount) they considered the patient should have used
for optimal efficacy (=‘current practice’) following the existing
guidelines. This was compared to an automated calculation
based on the affected BSA using the rule of hands, the picture-
guided instrument and the drawing tool. For the automated
calculation, a standard total BSA for men (1.9 m2) and women
(1.6 m2) was used. The optimal amount of ointment was calcu-
lated following the rules of the FTU.1 The reliability of the three
methods regarding determination of the affected BSA and the
estimation of the appropriate amount of ointment over a given
time period was investigated. The inter-rater and intrarater
agreement, timing and user-friendliness were assessed. Eight
observers repeated the scoring after a minimal interval of 1 week
to calculate the intrarater agreement. This study was approved
by the local ethics committee and was performed according to
the Declaration of Helsinki. The COSMIN checklist was used for
designing the protocol and reporting the results.
For calculation of ICC’s in reliability studies, a minimum
sample size of at least 30 cases involving at least three raters has
been proposed.6 As no general consensus exists on the optimal
sample size to study inter-rater and intrarater reliability in physi-
cian performed scoring tools, we ensured that the number of
patients and raters exceeded most comparable studies and per-
formed a sample size calculation based on the predefined statisti-
cal analyses.
Rule of hands combined with the ﬁngertip unit (=method 1)
The method assumes that on an affected skin area corresponding
with the surface area of 2 hands (=2% BSA), 1 FTU of ointment
should be applied.2
‘Pattern tool’ (=method 2)
A new instrument was developed consisting of six main (extent)
categories (2.5%, 10%, 25%, 50%, 75%, 100%), which are illus-
trated by a series of pictures, mimicking the most common distri-
bution patterns in psoriasis and eczema (Fig. 1). All categories can
be scored separately for 24 different body parts [head (front +
back), trunk (front + back), arms (left + right, front + back), hands
(left + right, front + back), genital area (front + back), legs
(left + right, front + back), feet (left + right, front + back), armpits
(left + right)]. Combined with the possibility to score ‘in between’
categories (0%, 6.25%, 17.5%, 37.5%, 87.5%), a huge amount of
different outcomes (11 categories for 24 body parts) can be gener-
ated, resulting in an almost continuous scale.
Design of the ‘drawing tool’ (=method 3)
A human silhouette (front and back) was drawn with separate
representations of the armpits and palmar sides of the feet. Dur-
ing the scoring sessions, the raters could mark the involved areas
using a pencil drawing tool in IMAGEJ software, National Institute
of Health, Bethesda, Maryland, USA. The percentage of involve-
ment was automatically calculated for each body part.
Timing and user-friendliness
The time required to score each patient was automatically
recorded using Excel, Microsoft, Redmond, Washington, USA.
At the end of the first session, the observers filled out a question-
naire to rate the user-friendliness, timing, accuracy and effort to
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complete the score for each method on a visual analogue scale
(0–10). The raters were asked to choose a preferred method if
physicians or patients would use the instrument.
Statistical analysis
The inter-rater agreement and intrarater agreement were deter-
mined using the intraclass correlation coefficient (ICC) in a
two-way random model with absolute agreement and reported
as single measures. In case the assumption of normality was not
met, log transformation was carried out before calculating the
ICC. Comparison between methods was performed using the
Mann–Whitney U-test. Pearson correlation was used to assess
the relation between different continuous variables. Bland–Alt-
man plots were generated to compare the results of the different
measuring techniques. All analyses were done using Medcalc
18.5 (Medcalc Software bvba, Ostend, Belgium) and SPSS 23.0
(SPSS Science, Chicago, IL, USA).
Results
Body surface area estimation
The mean BSA estimates using the rule of hands showed a very
high correlation with the picture-based instrument and the
drawing tool (r = 0.98 and r = 0.94, respectively; both
P < 0.001; Fig. 2). Similarly, the picture-guided instrument was
strongly correlated with the drawing tool (r = 0.93, P < 0.001).
Mean BSA values were not significantly different between the
first and the second methods. In contrast, the rule of hands
showed higher percentages compared to the drawing tool
(P = 0.035; Fig. 2d).
Figure 1 Template of the Cutaneous Inﬂammatory Disease Extent Score (CIDES). All 24 body parts can be scored separately. Scoring
can be done on the pictures (2.5%, 10%, 25%, 50%, 75%, 100%) combined with the possibility to score ‘in between’ categories (0%,
6.25%, 17.5%, 37.5%, 87.5%).
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Bland–Altman plots displayed a significant slope in the regres-
sion line between the rule of hands and the other two scoring
tools (P < 0.001 and P < 0.001, respectively; Fig. 3). This was
due to higher BSA estimations in patients with advanced disease
using the rule of hands compared to the other two methods. In
both situations, a proportional error was evident showing an
increased difference in patients with high BSA involvement. In
contrast, a Bland–Altman plot between the picture-based instru-
ment and the drawing tool showed no obvious differences.
Inter-rater and intrarater agreement
The inter-rater agreement was excellent for the picture-based
instrument [ICC = 0.92 (95% CI: 0.88–0.95)], which was fol-
lowed by the drawing tool [(ICC = 0.89 (0.83–0.94)] and finally
the rule of hands [ICC = 0.79 (95% CI: 0.66–0.88)]. The stan-
dard deviation between the scores of the raters was significantly
lower for the picture-based tool and the drawing tool compared
to the rule of hands (P < 0.001 and P < 0.001, respectively;
Fig. 4). The results were very consistent among raters with differ-
ent grades of experience.
The overall intrarater agreement was very high for all meth-
ods. An ICC of 0.95 (95% CI: 0.94–0.96) was observed for the
rule of hands, 0.96 (95% CI: 0.95–0.97) for the picture-based
instrument and 0.93 (95% CI: 0.92–0.95) for the ‘drawing’ tool.
The standard deviations between the first score and second score
were increased for the 1% hand rule compared to the other two
methods (P = 0.003 and P = 0.003, respectively).
Estimation of the amount of topical treatment
The estimation of the amount of ointment (grams) that should
be used during a fixed time period in order to achieve an opti-
mal response proved very difficult without additional aids.
Despite an excellent correlation (r = 0.95), non-automated esti-
mation resulted in higher mean values (of amount of cream)
compared to the automated calculation (Fig. 4). The inter-rater
ICC of the estimation without automated calculation was only
0.65 (0.48–0.78). Nonetheless, this is the most widely used stan-
dard practice. Automated calculation improved the ICC drasti-
cally. The picture-guided instrument resulted in the best ICC
(ICC = 0.94 (95% CI: 0.90–0.96)], followed by the drawing tool
[ICC = 0.91 (95% CI: 0.86–0.95)] and the rule of hands
[ICC = 0.82 (95% CI: 0.71–0.89)]. As expected from this result,
the SD between raters was significantly smaller for the picture-
based instrument and the drawing tool compared to the other
methods (Fig. 4e). Similarly, intrarater reliability estimation
without automated calculation showed an ICC of 0.64 (95% CI:
0.48–0.74), which was clearly lower compared to automated cal-
culation using the rule of hands [ICC = 0.95 (95% CI: 0.94–
0.96)], Cutaneous Inflammatory Disease Extent Score [CIDES;
ICC = 0.96 (95% CI: 0.95–0.97)] and the drawing tool
[ICC = 0.96 (95% CI: 0.95–0.97)]. Due to the increased variabil-
ity in patients needing a high amount of cream, the picture-
based instrument and the drawing tool displayed a decreased SD
(between the first and second scores of all raters) compared to
the rule of hands and the estimation without automated calcula-
tion (Fig. 4).
User-friendliness and timing
User-friendliness was scored in favour of the picture-based tool
(8.5/10), followed by the drawing tool (6.4/10) and the rule of
hands (5.3/10). The feeling of accuracy (8.3/10, 6.6/10 and 4/10,
respectively) and effort to complete the tool (3.6/10, 5.8/10, 6.8/
10, respectively) showed similar results. This all supports the
superior properties of a picture-based tool in daily practice com-
pared to the rule of hands. The mean duration of a score was
57 s (median 50 s; IQR: 40–64 s) for the rule of hands (+estima-
tion of the amount of product to prescribe) compared to 42 s
(median: 30 s; IQR: 16–44 s) for CIDES and 89 s (median: 80 s;
IQR: 59–116 s) for the drawing tool (both with automated cal-
culation of the amount of prescribed product). All observers
considered the pattern tool as the most appropriate tool for
physicians. 63.6% of raters found this instrument most appro-
priate for patients while 36.4% considered the ‘drawing’ tool to
be more suited for this purpose.
Discussion
Topical treatment remains the gold standard of care for mild-to-
moderate psoriasis and atopic dermatitis. In extensive cases, the
combination of systemic therapy with topicals is common prac-














































































Figure 2 The rule of hands was highly correlated with the picture-
based tool (CIDES) (a) and the drawing tool (b). Similarly, CIDES
was strongly correlated with the drawing tool (c). The rule of hands
resulted in the highest values, which was not signiﬁcantly different
from CIDES, although signiﬁcantly higher than the drawing tool (d).
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diseases and varies in clinical trials between 55% and 100%. In a
real-life situation, this is likely to be even less. A systematic
review found four studies which investigated the quantity of
topicals that patients actually applied and discovered that the
amount was 35–72% of the recommended dosage. The authors
therefore advised an increased use of clear user instructions.8
Recent studies in atopic dermatitis found that only 20.9–26.5%
of patients used the correct amount of tacrolimus and that treat-
ment efficacy significantly increased according to the applied
quantity.9,10 Interventions clarifying the correct use of topicals
have shown dramatic (89%) decreases in the severity of inade-
quately controlled childhood eczema.11 Additionally, a study
confirmed that 95% of psoriasis patients under dose their topical
treatment with current standard practice.12 The physician seems
– at least partly – to blame as almost two-thirds of topical pre-
scriptions for psoriasis do not include enough information for
patients to manage their disease properly.3 Moreover, the num-
ber of prescriptions has been documented to be insufficient in
one-fourth of cases with widespread eczema. It has been shown
that these patients are reluctant to ask additional prescriptions
out of fear for possible side-effects.13
In this article, we compared different methods to estimate
the body surface extent and calculate the dosage of topical
treatment for the most common inflammatory skin disorders:
psoriasis and atopic dermatitis. A new tool based on patterns
called ‘CIDES’ shows excellent inter-rater agreement and
intrarater agreement to estimate the affected BSA and amount
of topical treatment that should be used. This method
(=CIDES) outperformed the reliability of the FTU combined
with the rule of hands. CIDES was created based on our pre-
vious experience with a comparable method to measure the
body surface involvement of vitiligo named the Vitiligo
Extent Score.14 During several validation studies, its superior
user-friendliness and accuracy were shown over methods
using the rule of hands. Even in cases when the pattern of
the disease did not seem to correspond to the template, no
decreased reliability was observed. This led us to develop a
comparable tool for psoriasis and eczema, which now shows
to exhibit the same excellent results regarding inter-rater and
intrarater reliability and user-friendliness. The ‘drawing’ tool
showed also excellent inter-rater and intrarater reliability but
required substantially more time (more than double) and
















































Figure 3 Bland–Altman plots showed proportional error between the rule of hands and both the picture-guided instrument (CIDES) (a)
and the drawing tool (b), indicating that the rule of hands displays increased differences with both methods in patients with advanced
body surface involvement. No clear difference was found between picture-based instrument and the drawing tool.
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effort to complete and was not considered to be a practical
approach in clinical practice.
This study is the first phase of the development of a new digi-
tal easy-to-use application to calculate the dosage of topical
treatments and offer patients accurate user information. The pic-
ture-based method (CIDES) was faster and even slightly more
reliable compared to a ‘drawing tool’. It required very little
instructions and was easily understood by all participants. As the
extent of body surface involvement can change rapidly during
treatment, patients should themselves be capable to adjust the
dosage (benefiting the cost-effectiveness of the initiated therapy).




















































































































































































































































Figure 4 The standard deviation of the body surface area estimations (between raters) was higher using the rule of hands compared to
the other methods (a). Similarly, the standard deviation of the test–retest scores was highest using the role of hands followed by the draw-
ing tool and the picture-guided instrument (CIDES) (b). Estimation without an automated calculation resulted in higher weights of ointment
(c) displaying higher differences with increasing amounts (d). The standard deviation of the amount of treatment (grams) during a ﬁxed
time period was highest using the method without automated calculation (=‘current practice’) and was also higher using the rule of hands
compared to CIDES and the ‘drawing tool’ (e). Test–retest evaluations showed similar results (f).
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which will allow them to calculate independently their affected
BSA and adapt the dosage if the extent of their skin disease
changes over time. A limitation of this study was that all patients
were Caucasian. A multicultural international validation study
will be planned including more raters with different levels of
experience. For practical and analytical reasons, the study was
conducted on pictures instead of live evaluation of patients. In
the future, the value of using separate patterns for atopic der-
matitis and psoriasis in CIDES will be investigated.
In conclusion, this validation study shows that a picture-
guided tool outperforms the current gold standard (FTU based
on the rule of hands) in terms of inter-rater reliability and user-
friendliness. Given these superior characteristics, this instrument
can be used to calculate the affected BSA in inflammatory skin
disorders and will be integrated in a new digital tool to deter-
mine the dosage of topical treatments.
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